Paperpal Prime Logo

Journal of Hypertension : Impact Factor & More

eISSN: 1473-5598pISSN: 0263-6352

Aims and Scope of Journal of Hypertension

Journal of Hypertension is a peer-reviewed medical journal published by Lippincott Williams & Wilkins first launched in 1982. It is the official journal of the International Society of Hypertension and the European Society of Hypertension. The journal is published monthly and includes primary papers, reviews, special reports, and letters. Less

Key Metrics

CiteScore
6.9
Eigenfactor
0.01 - 0.05
Impact Factor
< 5
SJR
Q1Medicine (all)
SNIP
1.54
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Hypertension

Journal of Hypertension Journal Specifications

Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1983
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Hypertension ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Hypertension

Artificial intelligence and hypertension management: experience the journey but fasten your seatbelt.
  • 1 Sep 2026
  • Journal of hypertension
Transcriptomic analysis identifies novel ferroptosis-related biomarkers and therapeutic targets in pulmonary arterial hypertension.
  • 1 Sep 2026
  • Journal of hypertension
Explaining blood pressure reduction heterogeneity in sodium-glucose cotransporter-2 inhibitor trials: a meta-analysis stratified by patient characteristics.
  • 1 Sep 2026
  • Journal of hypertension
Can placental histology reveal preexisting hypertension in patients who develop preeclampsia?
  • 1 Sep 2026
  • Journal of hypertension
The effects of Astragalus membranaceus on inflammation and apoptosis in rats with preeclampisa.
  • 1 Sep 2026
  • Journal of hypertension
Methodological inconsistencies and nomenclature errors in 'Arterial hypertension-attributable mortality in Europe', 2012-2021.
  • 1 Sep 2026
  • Journal of hypertension
Artificial intelligence and hypertension management: experience the journey but fasten your seatbelt.
  • 1 Sep 2026
  • Journal of hypertension
Transcriptomic analysis identifies novel ferroptosis-related biomarkers and therapeutic targets in pulmonary arterial hypertension.
  • 1 Sep 2026
  • Journal of hypertension
Explaining blood pressure reduction heterogeneity in sodium-glucose cotransporter-2 inhibitor trials: a meta-analysis stratified by patient characteristics.
  • 1 Sep 2026
  • Journal of hypertension
Can placental histology reveal preexisting hypertension in patients who develop preeclampsia?
  • 1 Sep 2026
  • Journal of hypertension
The effects of Astragalus membranaceus on inflammation and apoptosis in rats with preeclampisa.
  • 1 Sep 2026
  • Journal of hypertension
Methodological inconsistencies and nomenclature errors in 'Arterial hypertension-attributable mortality in Europe', 2012-2021.
  • 1 Sep 2026
  • Journal of hypertension

FAQs on Journal of Hypertension